Medications Associated With Generalized Pustular Psoriasis Flares: A Retrospective Pharmacovigilance Study

Abstract

Keywords

generalized pustular psoriasis (GPP)spesolimab flare psoriasis

Get full access to this article

View all access options for this article.

References

Griffiths

CEM

Armstrong

Gudjonsson

Barker

. Psoriasis. Lancet. 2021;397(10281):1301-1315. doi:10.1016/S0140-6736(20)32549-6

Choon

Navarini

Pinter

Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):21-29. doi:10.1007/s40257-021-00654-z

Benjegerdes

Hyde

Kivelevitch

Mansouri

Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl). 2016;6:131-144. doi:10.2147/PTT.S98954

Kim

Del Rosso

JQ.

Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol. 2010;3(1):32-38.

Vasconcellos

Pereira

Vargas

Levy

Pinheiro

Cursi

IB.

Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis. An Bras Dermatol. 2016;91(5 Suppl 1):137-139. doi:10.1590/abd1806-4841.20164456

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB